Skip to content

Effectiveness of stress inoculation training approach on premenstrual syndrome

Effectiveness of stress inoculation training (SIT) counseling approach on anxiety, and depression of students with premenstrual syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230130057274N2
Enrollment
100
Registered
2023-12-31
Start date
2022-10-30
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety and depression. Mixed anxiety and depressive disorder

Interventions

Intervention 1: Intervention group: In the intervention group, SIT therapy method is performed individually, which includes 6 consecutive sessions (one session per week) and the duration of each sessi

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 38 Years

Inclusion criteria

Inclusion criteria: Being Iranian Students living in the student dormitory of Babol University of Medical Sciences Declaration of consent to participate in the study Having premenstrual syndrome Having regular menstrual cycles with intervals of 21 to 35 days and a duration of 3 to 7 days at least during the last six months Having 5 symptoms of premenstrual syndrome for two consecutive months Having symptoms of depression or anxiety with a score of 8 or higher Access to the smartphone Age range from 18 to 38 years

Exclusion criteria

Exclusion criteria: Use of antidepressants and anxiety medications during the study Participation in other psychological interventions such as psychotherapy, meditation, yoga Occurrence of stressful events at least six months before the start of the study Suffering from genital diseases and known and chronic underlying diseases Taking birth control pills Hormonal disorders and irregular menstruation Current or history of severe mental illness such as severe depression, bipolar disorder, and suicidal thoughts Drug addiction and consumption of psychoactive substances or alcohol

Design outcomes

Primary

MeasureTime frame
Anxiety. Timepoint: Before the intervention, immediately after the end of the intervention in the luteal phase, the first and second menstrual cycle after the intervention. Method of measurement: Hospital anxiety and depression questionnaire.;Depression. Timepoint: Before the intervention, immediately after the end of the intervention in the luteal phase, the first and second menstrual cycle after the intervention. Method of measurement: Hospital anxiety and depression questionnaire.

Secondary

MeasureTime frame
Stress. Timepoint: Before the intervention, immediately after the end of the intervention in the luteal phase, the first and second menstrual cycle after the intervention. Method of measurement: Perceived Stress Questionnaire 14.;Performance. Timepoint: Before the intervention, immediately after the end of the intervention in the luteal phase, the first and second menstrual cycle after the intervention. Method of measurement: Sheehan's Disability Questionnaire.;Psychological well-being. Timepoint: Before the intervention, immediately after the end of the intervention in the luteal phase, the first and second menstrual cycle after the intervention. Method of measurement: Riff's Psychological Well-Being Questionnaire.;Symptoms of premenstrual syndrome. Timepoint: Before the intervention, immediately after the end of the intervention in the luteal phase, the first and second menstrual cycle after the intervention. Method of measurement: Premenstrual Symptoms Screening Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHajar Adib-Rad

Babol University of Medical Sciences

Adibrad2015@yahoo.com+98 11 3219 0597

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026